Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate Risk Prostate Cancer (Diagnosis)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04486755
What this trial is testing

Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048)

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Maryland, Baltimore 18
Not applicableStudy completedNCT00693238
What this trial is testing

Proton Therapy for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Florida 228
Large-scale testing (Phase 3)Ended earlyNCT04457245
What this trial is testing

Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer

Who this might be right for
Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8+6 more
Jonsson Comprehensive Cancer Center 54
Testing effectiveness (Phase 2)Ended earlyNCT00924807
What this trial is testing

Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Beth Israel Medical Center 4
Testing effectiveness (Phase 2)Looking for participantsNCT05361798
What this trial is testing

A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy

Who this might be right for
Cancer Of Prostate
National Cancer Institute (NCI) 65
Testing effectiveness (Phase 2)Looking for participantsNCT06347705
What this trial is testing

2141-V11 in Combination With Standard Treatments in People With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 57
Early research (Phase 1)Study completedNCT00026377
What this trial is testing

SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Chicago 3
Not applicableStudy completedNCT01812902
What this trial is testing

Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical Prostatectomy

Who this might be right for
Prostate Cancer
University of Sao Paulo 260
Not applicableStudy completedNCT03424694
What this trial is testing

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
CR-CSSS Champlain-Charles-Le Moyne 199
Not applicableUnknownNCT02070952
What this trial is testing

CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Riverside Community Hospital, California 167
Not applicableStudy completedNCT00643617
What this trial is testing

CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry

Who this might be right for
Prostate CancerProstatic CancerProstatic Neoplasms+2 more
Accuray Incorporated 307
Not applicableLooking for participantsNCT05722392
What this trial is testing

Safety and Efficacy of Two-step Radical Prostatectomy

Who this might be right for
Prostate Cancer
Sun Yat-sen University 30
Testing effectiveness (Phase 2)UnknownNCT04523896
What this trial is testing

HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer

Who this might be right for
Prostatic Neoplasm
David Büchser 50
Not applicableStudy completedNCT02104362
What this trial is testing

Single Fraction Early Prostate Irradiation (SiFEPI)

Who this might be right for
Prostate Cancer
Centre Antoine Lacassagne 35
Testing effectiveness (Phase 2)Study completedNCT02903368
What this trial is testing

Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 118
Not applicableStudy completedNCT00218179
What this trial is testing

Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1

Who this might be right for
Tobacco Use DisorderLung Cancer
University of Minnesota 200
Early research (Phase 1)Active Not RecruitingNCT01655836
What this trial is testing

High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 42
Testing effectiveness (Phase 2)Ended earlyNCT00084864
What this trial is testing

Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute 25
Not applicableActive Not RecruitingNCT06434649
What this trial is testing

Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer

Who this might be right for
Surgical Procedure, UnspecifiedProstate Cancer
Ning Xu 118
Not applicableApproved For MarketingNCT04809584
What this trial is testing

18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer

Who this might be right for
Prostate Cancer
Stanford University
Next Page